Increase/Decrease in Cash: The total change in cash for the company over the given period.
EUROFINS SCIENT (ERFSF) had Increase/Decrease in Cash of $-657.59M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.65B |
|
$5.88B |
|
$12.24B |
|
$11.78B |
|
$2.28B |
|
$3.39B |
|
$3.67B |
|
$5.96B |
|
$5.83B |
|
$-263.81M |
|
$5.83B |
|
-- |
|
| Cash Flow Statement Financials | |
$1.43B |
|
$-916.00M |
|
$-1.18B |
|
$1.32B |
|
$663.54M |
|
|
Increase/Decrease in Cash |
$-657.59M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|